Observatory of ATTR amyloidosis and of patients treated with Vyndaqel® (tafamidis) OBSAMYL study

First published 09/07/2018

Last updated 23/04/2024

EU PAS number:

EUPAS24718

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

OBSAMYL_protocole v3.0_20180329_VF

English (1.4 MB - PDF) View document

Study results

Summary_results_V6.6 rapport_20201014

English (92.39 KB - PDF) View document

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Signed checklist for study protocols

PFE Scan

English (371.91 KB - PDF) View document

Observatory of ATTR amyloidosis and of patients treated with Vyndaqel® (tafamidis) OBSAMYL study

Secondary tabs

Share this page